InSilicoTrials Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Employees
  • 22

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $17.5M

  • Investors
  • 12

InSilicoTrials General Information

Description

Operator of a cloud-based scientific innovation platform intended to accelerate drug development. The company offers computational models and artificial intelligence technology to analyze large amounts of data and predict the safety and efficacy of potential drug compounds, enabling pharmaceutical, biotech, and researchers to cut research costs, reduce and replace animal testing and clinical trials, and improve the safety of new medical products.

Contact Information

Website
www.insilicotrials.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Riva Grumula, 2
  • 34123 Trieste
  • Italy
Primary Industry
Enterprise Systems (Healthcare)
Other Industries
Drug Discovery
Other Healthcare Technology Systems
Vertical(s)
Artificial Intelligence & Machine Learning, HealthTech, Life Sciences
Corporate Office
  • Riva Grumula, 2
  • 34123 Trieste
  • Italy

InSilicoTrials Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

InSilicoTrials Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Later Stage VC (Series A) 16-Jul-2025 $17.5M Completed Generating Revenue
9. Later Stage VC 07-Mar-2024 Completed Generating Revenue
8. Accelerator/Incubator 01-Jan-2024 Completed Generating Revenue
7. Accelerator/Incubator 08-Nov-2023 Completed Generating Revenue
6. Grant 15-Nov-2020 Completed Generating Revenue
5. Seed Round 30-Jul-2020 Completed Generating Revenue
4. Seed Round 30-Jun-2020 Completed Generating Revenue
3. Angel (individual) 30-Jun-2018 Completed Generating Revenue
2. Seed Round 08-Oct-2017 $356K $356K Completed Startup
1. Grant 01-Mar-2017 $532K Completed Startup
To view InSilicoTrials’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

InSilicoTrials Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a cloud-based scientific innovation platform intended to accelerate drug development. The company offers com
Enterprise Systems (Healthcare)
Trieste, Italy
22 As of 2026

Tel Aviv, Israel
 

Paris, France
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

InSilicoTrials Competitors (10)

One of InSilicoTrials’s 10 competitors is QuantHealth, a Venture Capital-Backed company based in Tel Aviv, Israel.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
QuantHealth Venture Capital-Backed Tel Aviv, Israel
Owkin Venture Capital-Backed Paris, France
VeriSIM Life Venture Capital-Backed San Francisco, CA
Nova in Silico Venture Capital-Backed Lyon, France
Aitia Venture Capital-Backed Cambridge, MA
You’re viewing 5 of 10 competitors. Get the full list »

InSilicoTrials Patents

  • 15

    Total Documents Applications and Grants

  • Total Patents Families

  • 2

    Granted

  • 10

    Pending

  • Expiring in next 12 mo

InSilicoTrials Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2024259684-A1 Method and system for computational modeling and simulation applied to drug characterization and/or optimization Inactive 28-Mar-2018
JP-2024023697-A Method and system for computational modeling and simulation applied to drug characterization and/or optimization Pending 28-Mar-2018
AU-2019244686-A1 Method and system for computational modeling and simulation of the operation and/or behavior of medical devices which are implantable or usable on patients Inactive 28-Mar-2018
AU-2024259683-A1 Method and system for computational modeling and simulation of the operation and/or behavior of medical devices which are implantable or usable on patients Pending 28-Mar-2018
CA-3094920-A1 Method and system for computational modeling and simulation of the operation and/or behavior of medical devices which are implantable or usable on patients Pending 28-Mar-2018 A61B34/10
To view InSilicoTrials’s complete patent history, request access »

InSilicoTrials Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

InSilicoTrials Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds
B-Yond Ventures Venture Capital Minority
Deep Ocean Capital Venture Capital Minority
Moonstone Fund Venture Capital Minority
Endeavor Italy Accelerator/Incubator
DayOne Accelerator Accelerator/Incubator
You’re viewing 5 of 12 investors. Get the full list »

InSilicoTrials Acquisitions (1)

InSilicoTrials’s most recent deal was a Merger/Acquisition with CONSELF. The deal was made on 01-Jan-2018.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
CONSELF 01-Jan-2018 Merger/Acquisition Systems and Information Management
To view InSilicoTrials’s complete acquisitions history, request access »

Ready to get started?

Request a free trial

InSilicoTrials FAQs

  • When was InSilicoTrials founded?

    InSilicoTrials was founded in 2017.

  • Where is InSilicoTrials headquartered?

    InSilicoTrials is headquartered in Trieste, Italy.

  • What is the size of InSilicoTrials?

    InSilicoTrials has 22 total employees.

  • What industry is InSilicoTrials in?

    InSilicoTrials’s primary industry is Enterprise Systems (Healthcare).

  • Is InSilicoTrials a private or public company?

    InSilicoTrials is a Private company.

  • What is InSilicoTrials’s current revenue?

    The current revenue for InSilicoTrials is .

  • How much funding has InSilicoTrials raised over time?

    InSilicoTrials has raised $29.8M.

  • Who are InSilicoTrials’s investors?

    B-Yond Ventures, Deep Ocean Capital, Moonstone Fund, Endeavor Italy, and DayOne Accelerator are 5 of 12 investors who have invested in InSilicoTrials.

  • Who are InSilicoTrials’s competitors?

    QuantHealth, Owkin, VeriSIM Life, Nova in Silico, and Aitia are some of the 10 competitors of InSilicoTrials.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process